Health innovations from the world’s poor countries have passed the test of scalability and applicability in the places that need them most. With most of the world’s population living in resource-challenged settings, investment in those who are pushing the frontiers of medical science in the developing world would yield high returns.
DHAKA – We live in an age of tragic health paradoxes. Mass immunization campaigns have eliminated entire diseases, but children in countries like Haiti and Bangladesh continue to die of easily treatable diseases caused by common pathogens. Globalization has lifted millions of people out of extreme poverty, but has left them exposed to the non-communicable diseases of the post-industrial age – from diabetes to heart disease – in countries that lack the resources to treat them.
DHAKA – We live in an age of tragic health paradoxes. Mass immunization campaigns have eliminated entire diseases, but children in countries like Haiti and Bangladesh continue to die of easily treatable diseases caused by common pathogens. Globalization has lifted millions of people out of extreme poverty, but has left them exposed to the non-communicable diseases of the post-industrial age – from diabetes to heart disease – in countries that lack the resources to treat them.